Jane Street
NUVB icon

Jane Street’s Nuvation Bio NUVB Stock Holding History

Jane Street’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$483K Sell
85,000
-105,800
-55% -$517K ﹤0.01% 8105
2026
Q1 		$819K Buy
190,800
+61,300
+47% +$342K ﹤0.01% 6932
2025
Q4 		$1.16M Buy
129,500
+45,500
+54% +$282K ﹤0.01% 5830
2025
Q3 		$311K Buy
+84,000
New +$229K ﹤0.01% 8833

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jane Street's NUVB Position: Q1 2026 in Review

Jane Street sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 530,077 shares — an estimated $2.95M sold.

Jane Street first reported a position in NUVB in Q1 2021 and held it in 17 quarters. The position peaked at $8.59M in Q3 2025. 233 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Jane Street reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 530,077 Nuvation Bio shares in Q1 2026, an estimated $2.95M.
  • Jane Street first reported a position in Nuvation Bio in Q1 2021 and held it in 17 quarters.
  • Jane Street's Nuvation Bio position peaked at $8.59M in Q3 2025.
  • 233 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.